JP2019218408A5 - - Google Patents

Download PDF

Info

Publication number
JP2019218408A5
JP2019218408A5 JP2019182761A JP2019182761A JP2019218408A5 JP 2019218408 A5 JP2019218408 A5 JP 2019218408A5 JP 2019182761 A JP2019182761 A JP 2019182761A JP 2019182761 A JP2019182761 A JP 2019182761A JP 2019218408 A5 JP2019218408 A5 JP 2019218408A5
Authority
JP
Japan
Prior art keywords
fibroblasts
injectable composition
positive
sorting
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019182761A
Other languages
English (en)
Japanese (ja)
Other versions
JP7072135B2 (ja
JP2019218408A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019218408A publication Critical patent/JP2019218408A/ja
Publication of JP2019218408A5 publication Critical patent/JP2019218408A5/ja
Application granted granted Critical
Publication of JP7072135B2 publication Critical patent/JP7072135B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019182761A 2017-02-24 2019-10-03 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法 Active JP7072135B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017033624 2017-02-24
JP2017033624 2017-02-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019501845A Division JP6618066B2 (ja) 2017-02-24 2018-02-23 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法

Publications (3)

Publication Number Publication Date
JP2019218408A JP2019218408A (ja) 2019-12-26
JP2019218408A5 true JP2019218408A5 (enExample) 2021-04-08
JP7072135B2 JP7072135B2 (ja) 2022-05-20

Family

ID=63253929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019501845A Active JP6618066B2 (ja) 2017-02-24 2018-02-23 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法
JP2019182761A Active JP7072135B2 (ja) 2017-02-24 2019-10-03 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019501845A Active JP6618066B2 (ja) 2017-02-24 2018-02-23 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法

Country Status (12)

Country Link
US (2) US11096969B2 (enExample)
EP (1) EP3476395B1 (enExample)
JP (2) JP6618066B2 (enExample)
KR (1) KR102407387B1 (enExample)
CN (1) CN109890398B (enExample)
AU (1) AU2018223739B2 (enExample)
CA (1) CA3032654A1 (enExample)
DK (1) DK3476395T3 (enExample)
ES (1) ES2885080T3 (enExample)
IL (1) IL267958B2 (enExample)
SG (1) SG11201900810WA (enExample)
WO (1) WO2018155651A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3110831A1 (en) 2018-08-29 2020-03-05 Metcela Inc. Method for producing fibroblast, and g-csf-positive fibroblast mass
CN109589337B (zh) 2018-12-29 2022-04-26 南京艾尔普再生医学科技有限公司 心肌细胞制剂及其制备方法和应用
IL296125A (en) 2020-03-04 2022-11-01 Metcela Inc Fibroblasts have an increased ability to produce erythropoietin
AU2022231584A1 (en) * 2021-03-04 2023-09-07 Lymphogenix Limited Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same
US20240316113A1 (en) * 2021-09-08 2024-09-26 Metcela Inc. Fibroblast-containing pharmaceutical composition for treating kidney disease
EP4249585A1 (en) * 2022-03-25 2023-09-27 Technische Universität München - TUM Heart tissue models, method of producing heart tissue models and uses of heart tissue models

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
CA2487254A1 (en) * 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for treating cardiac arrhythmias with fibroblast cells
AU2003239418B2 (en) * 2002-05-08 2008-01-31 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20040161412A1 (en) * 2002-08-22 2004-08-19 The Cleveland Clinic Foundation Cell-based VEGF delivery
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
CN101415458A (zh) * 2003-11-10 2009-04-22 辛弗尼医药有限公司 控制心房纤维性颤动患者心室律的方法
US8513011B2 (en) * 2004-08-26 2013-08-20 Biotech Research Ventures Pte Limited Methods and compositions for culturing cardiomyocyte-like cells
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
JP5378743B2 (ja) 2008-09-30 2013-12-25 テルモ株式会社 医療用細胞シートの製造方法
WO2013028968A1 (en) * 2011-08-25 2013-02-28 Wisconsin Alumni Research Foundation 3-dimensional cardiac fibroblast derived extracellular matrix
EP2826855B1 (en) 2012-03-15 2018-08-29 iHeart Japan Corporation Myocardial sheet
US20140072611A1 (en) * 2012-09-07 2014-03-13 Fibrocell Technologies, Inc. Methods and Compositions for Treating Post-Cardial Infarction Damage
GB201309057D0 (en) * 2013-05-20 2013-07-03 Cell Therapy Ltd Method
KR20150009655A (ko) * 2013-07-16 2015-01-27 학교법인 동아학숙 Gcp-2 유전자를 과발현하는 지방 간엽줄기세포를 포함하는 허혈성 질환 치료용 조성물
CA2954743C (en) * 2014-07-11 2022-03-15 Metcela Inc. Cardiac cell culture material

Similar Documents

Publication Publication Date Title
JP2019218408A5 (enExample)
Greco et al. Multiple criteria sorting with a set of additive value functions
CMS Collaboration cms-publication-committee-chair@ cern. ch et al. Search for supersymmetry in hadronic final states with missing transverse energy using the variables α T and b-quark multiplicity in pp collisions at
Zhou et al. Carbon dioxide emissions allocation: A review
Tellado et al. Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors
Labbi et al. A new rooted tree optimization algorithm for economic dispatch with valve-point effect
Lücking et al. Ediacarans, protolichens, and lichen-derived Penicillium: a critical reassessment of the evolution of lichenization in fungi
JP2021509912A5 (enExample)
WO2020243448A8 (en) Actrii-binding proteins and uses thereof
WO2017070131A3 (en) Particles for malodor reduction
JP2008527066A5 (enExample)
WO2015004539A3 (en) Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins ln-511, ln-521 and ln-221
EP3957661A8 (en) Polymerizable compositions containing (meth)acrylate monomers having sulfide linkages
MX2020009706A (es) Composicion fotocromica curable.
Fernandes et al. C-groups of high rank for the symmetric groups
WO2017017208A8 (en) Active cathode material and its use in rechargeable electrochemical cells
EP4082064C0 (fr) Procédé de fabrication de batteries à ions de lithium, notamment à forte puissance, et batterie obtenue par ce procédé
EP3959292C0 (en) NARROW-EMISSION DYES, COMPOSITIONS CONTAINING THEM, AND METHODS OF PRODUCTION AND USE THEREOF
EP4324803C0 (en) MECHANO-CHEMICALLY CARBONATED SLAG, ITS PRODUCTION PROCESSES AND USES
Zhao Affine Grassmannians for triality groups
Narain Bechain Patton Ka Chorus
WO2018097726A8 (en) Process
WO2020107032A3 (en) Method for utilizing dimensional manipulation
Pettenghi et al. Method for designing two levels RNS reverse converters for large dynamic ranges
EP4524207A3 (en) Photostabilizing compounds, compositions, and methods